AVAH Stock Analysis: Buy, Sell, or Hold?
AVAH - Aveanna Healthcare Holdings Inc. Common Stock
$8.47
0.27 (3.29%)
▲
5d:
+12.63%
30d:
+15.55%
90d:
+28.14%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When AVAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: AVAH is 8.5% above its trading range ($7.81). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: AVAH is 8.5% above its trading range ($7.81). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.49
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$7.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVAH is currently trading at $8.47, which is considered extended relative to its 30-day fair value range of $6.78 to $7.81. The stock's valuation (Forward PE: 11.0) is in line with its historical norms (11.6). Remarkably, the market is currently pricing in an annual earnings decline of 1.7% over the next few years. This pessimistic expectation contrasts with the company's recent 612.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AVAH is in a uptrend. The price is approaching resistance at $8.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: AVAH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.05 (+18.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AVAH is in a uptrend. The price is approaching resistance at $8.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: AVAH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.05 (+18.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.78 -
$7.81
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
59.5%
All Signals
- BEARISH: Price extended above range (+8.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- BULLISH: Trading below Wall St target ($10.05)
Trading Range Analysis
30-Day Trading Range
$6.78 -
$7.81
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.81
Resistance Level
$8.63
Current Trend
Uptrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.00
Wall Street Target
$10.05
(+18.7%)
Revenue Growth (YoY)
15.9%
Earnings Growth (YoY)
612.3%
Profit Margin
10.4%
Valuation Discount vs History
-1.7% cheaper
PE vs Historical
11.0 vs 11.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.7%
(market-implied from PE analysis)
1-Year Target
$8.33
(-2%)
2-Year Target
$8.18
(-3%)
3-Year Target
$8.05
(-5%)
3-Yr Target (if PE normalizes)
(PE: 11→12)
$8.49
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.9%)
$22.26
(+163%)
Base:
(SPY PE: 11.0, Growth: 9.9%)
$11.24
(+33%)
Bear:
(PE: 9.3, Growth: 9.9%)
$9.55
(+13%)
📈
Valuation based on Current Earnings
Trailing PE: 6.55 | Current EPS (TTM): $1.21
Bull Case
$5.54
(-32%)
Analyst growth -36.4%, PE expands to 7.2
Base Case
$5.04
(-39%)
Market implied -36.4%, PE stable at 6.6
Bear Case
$5.39
(-34%)
Severe decline -20.0%, PE contracts to 5.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.0 to 11.6
Stabilization Target:
$8.93
(+5.5%)
PE Expansion Potential:
+5.5%
Share & Embed Analysis
Last updated: June 24, 2026 5:44 PM ET
Data refreshes hourly during market hours. Next update: 6:44 PM
Data refreshes hourly during market hours. Next update: 6:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Deborah Stewart
SELL
11181 shares
2026-02-19
Patrick A Cunningham
SELL
18436 shares
2026-02-19
Jeff Shaner
SELL
173225 shares
2026-02-19
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
